{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T01:38:35Z","timestamp":1790127515186,"version":"4.0.1"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,23]],"date-time":"2025-04-23T00:00:00Z","timestamp":1745366400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,4,23]],"date-time":"2025-04-23T00:00:00Z","timestamp":1745366400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82270345"],"award-info":[{"award-number":["82270345"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Capital\u2019s Funds for Health Improvement and Research","award":["CFH2024-1-2061"],"award-info":[{"award-number":["CFH2024-1-2061"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-98010-2","type":"journal-article","created":{"date-parts":[[2025,4,23]],"date-time":"2025-04-23T06:18:39Z","timestamp":1745389119000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Cer(d18:1\/16:0) as a biomarkers for acute coronary syndrome in Chinese populations"],"prefix":"10.1038","volume":"15","author":[{"given":"Liang","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"YaoDong","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tong","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"XiaoFang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,23]]},"reference":[{"key":"98010_CR1","doi-asserted-by":"crossref","unstructured":"Roy, P., Orecchioni, M. & Ley, K. How the immune system shapes atherosclerosis: roles of innate and adaptive immunity. Nat. Rev. Immunol. (2021).","DOI":"10.1038\/s41577-021-00584-1"},{"key":"98010_CR2","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1146\/annurev-med-100119-013612","volume":"72","author":"A Hussain","year":"2021","unstructured":"Hussain, A. & Ballantyne, C. M. New approaches for the prevention and treatment of cardiovascular disease: Focus on lipoproteins and inflammation. Annu. Rev. Med. 72, 431\u2013446 (2021).","journal-title":"Annu. Rev. Med."},{"key":"98010_CR3","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1038\/s41569-021-00536-1","volume":"18","author":"RH Choi","year":"2021","unstructured":"Choi, R. H. et al. Ceramides and other sphingolipids as drivers of cardiovascular disease. Nat. Rev. Cardiol. 18, 701\u2013711 (2021).","journal-title":"Nat. Rev. Cardiol."},{"key":"98010_CR4","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.cca.2020.10.005","volume":"511","author":"JW Meeusen","year":"2020","unstructured":"Meeusen, J. W. et al. Ceramides improve atherosclerotic cardiovascular disease risk assessment beyond standard risk factors. Clin. Chim. Acta 511, 138\u2013142 (2020).","journal-title":"Clin. Chim. Acta"},{"key":"98010_CR5","doi-asserted-by":"publisher","first-page":"570628","DOI":"10.3389\/fendo.2020.570628","volume":"11","author":"M Hilvo","year":"2020","unstructured":"Hilvo, M. et al. Ceramides and ceramide scores: Clinical applications for cardiometabolic risk stratification. Front. Endocrinol. 11, 570628 (2020).","journal-title":"Front. Endocrinol."},{"issue":"3","key":"98010_CR6","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1016\/j.jacl.2022.02.001","volume":"16","author":"AS Papazoglou","year":"2022","unstructured":"Papazoglou, A. S. et al. CERT2 ceramide- and phospholipid-based risk score and major adverse cardiovascular events: A systematic review and meta-analysis. J. Clin. Lipidol. 16(3), 272\u2013276 (2022).","journal-title":"J. Clin. Lipidol."},{"issue":"15","key":"98010_CR7","doi-asserted-by":"publisher","first-page":"12452","DOI":"10.3390\/ijms241512452","volume":"24","author":"AE Rigamonti","year":"2023","unstructured":"Rigamonti, A. E. et al. Ceramide risk score in the evaluation of metabolic syndrome: An additional or substitutive biochemical marker in the clinical practice?. Int. J. Mol. Sci. 24(15), 12452 (2023).","journal-title":"Int. J. Mol. Sci."},{"issue":"24","key":"98010_CR8","first-page":"00224","volume":"S1933\u20132874","author":"L Zhang","year":"2024","unstructured":"Zhang, L. et al. The relationship between ceramide profile and residual inflammatory risk in patients with coronary artery disease: Insights from an prospective study. J. Clin. Lipidol. S1933\u20132874(24), 00224\u201300231 (2024).","journal-title":"J. Clin. Lipidol."},{"issue":"11","key":"98010_CR9","doi-asserted-by":"publisher","first-page":"e2343854","DOI":"10.1001\/jamanetworkopen.2023.43854","volume":"6","author":"LB Bockus","year":"2023","unstructured":"Bockus, L. B. et al. Plasma ceramides and sphingomyelins and sudden cardiac death in the cardiovascular health study. JAMA Netw. Open 6(11), e2343854 (2023).","journal-title":"JAMA Netw. Open"},{"key":"98010_CR10","doi-asserted-by":"publisher","first-page":"1177765","DOI":"10.3389\/fphys.2023.1177765","volume":"14","author":"L Zhang","year":"2023","unstructured":"Zhang, L. et al. Ceramides and metabolic profiles of patients with acute coronary disease: A cross-sectional study. Front. Physiol. 14, 1177765 (2023).","journal-title":"Front. Physiol."},{"key":"98010_CR11","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.atherosclerosis.2020.04.008","volume":"302","author":"W Pan","year":"2020","unstructured":"Pan, W. et al. Relationship between elevated plasma ceramides and plaque rupture in patients with ST-segment elevation myocardial infarction. Atherosclerosis 302, 8\u201314 (2020).","journal-title":"Atherosclerosis"},{"issue":"1","key":"98010_CR12","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1007\/s12265-020-09978-3","volume":"14","author":"W Pan","year":"2021","unstructured":"Pan, W. et al. Plasma ceramides in relation to coronary plaque characterization determined by optical coherence tomography. J. Cardiovasc. Transl. Res. 14(1), 140\u2013149 (2021).","journal-title":"J. Cardiovasc. Transl. Res."},{"issue":"25","key":"98010_CR13","doi-asserted-by":"publisher","first-page":"1967","DOI":"10.1093\/eurheartj\/ehw148","volume":"37","author":"R Laaksonen","year":"2016","unstructured":"Laaksonen, R. et al. Plasma ceramides predict cardiovascular death in patients with stable coronary artery disease and acute coronary syndromes beyond LDL-cholesterol. Eur. Heart J. 37(25), 1967\u20131976 (2016).","journal-title":"Eur. Heart J."},{"issue":"13","key":"98010_CR14","doi-asserted-by":"publisher","first-page":"e032536","DOI":"10.1161\/JAHA.123.032536","volume":"13","author":"AM Fretts","year":"2024","unstructured":"Fretts, A. M. et al. Circulating sphingolipids and all-cause mortality: The strong heart family study. J. Am. Heart Assoc. 13(13), e032536 (2024).","journal-title":"J. Am. Heart Assoc."},{"issue":"21","key":"98010_CR15","doi-asserted-by":"publisher","first-page":"1624","DOI":"10.1161\/CIRCULATIONAHA.123.065409","volume":"149","author":"Q Zhu","year":"2024","unstructured":"Zhu, Q. & Scherer, P. E. Ceramides and atherosclerotic cardiovascular disease: A current perspective. Circulation 149(21), 1624\u20131626 (2024).","journal-title":"Circulation"},{"issue":"2","key":"98010_CR16","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.jacl.2020.01.005","volume":"14","author":"A Mantovani","year":"2020","unstructured":"Mantovani, A. & Dugo, C. Ceramides and risk of major adverse cardiovascular events: A meta-analysis of longitudinal studies. J. Clin. Lipidol. 14(2), 176\u2013185 (2020).","journal-title":"J. Clin. Lipidol."},{"key":"98010_CR17","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1016\/j.tem.2015.07.006","volume":"26","author":"B Chaurasia","year":"2015","unstructured":"Chaurasia, B. & Summers, S. A. Ceramides\u2014lipotoxic inducers of metabolic disorders. Trends Endocrinol. Metab. 26, 538\u2013550 (2015).","journal-title":"Trends Endocrinol. Metab."},{"key":"98010_CR18","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1016\/j.cmet.2014.08.002","volume":"20","author":"SM Turpin","year":"2014","unstructured":"Turpin, S. M. et al. Obesity-induced CerS6-dependent C16:0 ceramide production promotes weight gain and glucose intolerance. Cell. Metab. 20, 678\u2013686 (2014).","journal-title":"Cell. Metab."},{"key":"98010_CR19","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1016\/j.redox.2017.06.004","volume":"13","author":"S Koka","year":"2017","unstructured":"Koka, S. et al. Endothelial NLRP3 inflammasome activation and arterial neointima formation associated with acid sphingomyelinase during hypercholesterolemia. Redox Biol. 13, 336\u2013344 (2017).","journal-title":"Redox Biol."},{"issue":"6","key":"98010_CR20","doi-asserted-by":"publisher","first-page":"1536","DOI":"10.1016\/j.cell.2019.05.008","volume":"177","author":"P Hammerschmidt","year":"2019","unstructured":"Hammerschmidt, P. et al. CerS6-derived sphingolipids interact with Mff and promote mitochondrial fragmentation in obesity. Cell 177(6), 1536-1552.e23 (2019).","journal-title":"Cell"},{"key":"98010_CR21","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/bs.pmbts.2017.01.004","volume":"147","author":"BA Brown","year":"2017","unstructured":"Brown, B. A., Williams, H. & George, S. J. Evidence for the involvement of matrix-degrading metalloproteinases (MMPs) in atherosclerosis. Prog. Mol. Biol. Transl. Sci. 147, 197\u2013237 (2017).","journal-title":"Prog. Mol. Biol. Transl. Sci."},{"key":"98010_CR22","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.1172\/JCI118934","volume":"98","author":"SL Schissel","year":"1996","unstructured":"Schissel, S. L. et al. Rabbit aorta and human atherosclerotic lesions hydrolyze the sphingomyelin of retained low-density lipoprotein. Proposed role for arterial-wall sphingomyelinase in subendothelial retention and aggregation of atherogenic lipoproteins. J. Clin. Invest. 98, 1455\u20131464 (1996).","journal-title":"J. Clin. Invest."},{"key":"98010_CR23","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.1161\/ATVBAHA.116.305675","volume":"36","author":"A Edsfeldt","year":"2016","unstructured":"Edsfeldt, A. et al. Sphingolipids contribute to human atherosclerotic plaque inflammation. Arterioscler. Thromb. Vasc. Biol. 36, 1132\u20131140 (2016).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"98010_CR24","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1111\/j.1365-2796.2008.01947.x","volume":"263","author":"T Thim","year":"2008","unstructured":"Thim, T., Hagensen, M. K., Bentzon, J. F. & Falk, E. From vulnerable plaque to atherothrombosis. J. Intern. Med. 263, 506\u2013516 (2008).","journal-title":"J. Intern. Med."},{"key":"98010_CR25","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1111\/dme.13943","volume":"37","author":"H Yaribeygi","year":"2020","unstructured":"Yaribeygi, H., Bo, S., Ruscica, M. & Sahebkar, A. Ceramides and diabetes mellitus: An update on the potential molecular relationships. Diabet Med. 37, 11\u201319. https:\/\/doi.org\/10.1111\/dme.13943 (2020).","journal-title":"Diabet Med."},{"key":"98010_CR26","doi-asserted-by":"publisher","first-page":"577","DOI":"10.3389\/fendo.2019.00577","volume":"10","author":"E Sokolowska","year":"2019","unstructured":"Sokolowska, E. & Blachnio-Zabielska, A. The role of ceramides in insulin resistance. Front. Endocrinol. 10, 577. https:\/\/doi.org\/10.3389\/fendo.2019.00577 (2019).","journal-title":"Front. Endocrinol."},{"issue":"20","key":"98010_CR27","doi-asserted-by":"publisher","first-page":"1936","DOI":"10.1161\/CIRCULATIONAHA.115.019351","volume":"133","author":"EL Brittain","year":"2016","unstructured":"Brittain, E. L. et al. Fatty acid metabolic defects and right ventricular lipotoxicity in human pulmonary arterial hypertension. Circulation 133(20), 1936\u20131944 (2016).","journal-title":"Circulation"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-98010-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-98010-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-98010-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,23]],"date-time":"2025-04-23T06:18:41Z","timestamp":1745389121000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-98010-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,23]]},"references-count":27,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["98010"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-98010-2","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,23]]},"assertion":[{"value":"9 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This study complied with the Declaration of Helsinki and received approval from the Ethics Committee of Beijing Anzhen Hospital, affiliated with Capital Medical University.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors have reviewed and approved the final version of the manuscript. All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}],"article-number":"14014"}}